Balance Wealth LLC Takes $274,000 Position in Johnson & Johnson (NYSE:JNJ)

Balance Wealth LLC acquired a new stake in Johnson & Johnson (NYSE:JNJ - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 1,652 shares of the company's stock, valued at approximately $274,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Global Assets Advisory LLC raised its position in Johnson & Johnson by 187.3% during the first quarter. Global Assets Advisory LLC now owns 19,735 shares of the company's stock worth $2,988,000 after acquiring an additional 12,866 shares during the last quarter. Steph & Co. raised its position in Johnson & Johnson by 6.8% during the first quarter. Steph & Co. now owns 5,964 shares of the company's stock worth $989,000 after acquiring an additional 381 shares during the last quarter. Silver Lake Advisory LLC grew its holdings in shares of Johnson & Johnson by 1.0% during the first quarter. Silver Lake Advisory LLC now owns 33,750 shares of the company's stock worth $5,597,000 after buying an additional 320 shares in the last quarter. Horizon Bancorp Inc. IN raised its position in shares of Johnson & Johnson by 406.2% in the first quarter. Horizon Bancorp Inc. IN now owns 572 shares of the company's stock valued at $95,000 after buying an additional 459 shares during the last quarter. Finally, Moran Wealth Management LLC raised its position in shares of Johnson & Johnson by 18.9% in the first quarter. Moran Wealth Management LLC now owns 101,280 shares of the company's stock valued at $16,796,000 after buying an additional 16,115 shares during the last quarter. Institutional investors and hedge funds own 69.55% of the company's stock.

Analyst Ratings Changes

JNJ has been the subject of a number of analyst reports. Royal Bank Of Canada reissued an "outperform" rating and issued a $181.00 price objective on shares of Johnson & Johnson in a research report on Thursday, June 5th. Leerink Partnrs lowered shares of Johnson & Johnson from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, May 13th. Wall Street Zen raised shares of Johnson & Johnson from a "buy" rating to a "strong-buy" rating in a research report on Saturday, June 21st. Morgan Stanley boosted their price objective on shares of Johnson & Johnson from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Wednesday, April 16th. Finally, Benchmark raised shares of Johnson & Johnson to a "strong-buy" rating in a research report on Thursday, April 24th. Eleven research analysts have rated the stock with a hold rating, seven have given a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $170.88.

Johnson & Johnson Trading Up 0.3%

JNJ traded up $0.43 during trading on Friday, hitting $152.44. 9,999,068 shares of the company's stock were exchanged, compared to its average volume of 8,019,610. The company has a current ratio of 1.26, a quick ratio of 1.03 and a debt-to-equity ratio of 0.49. Johnson & Johnson has a 1 year low of $140.68 and a 1 year high of $169.99. The stock has a 50 day moving average price of $153.85 and a 200 day moving average price of $153.69. The firm has a market cap of $366.78 billion, a P/E ratio of 16.96, a price-to-earnings-growth ratio of 2.31 and a beta of 0.42.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last released its quarterly earnings data on Tuesday, April 15th. The company reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.59 by $0.18. Johnson & Johnson had a net margin of 24.42% and a return on equity of 33.46%. The company had revenue of $21.89 billion during the quarter, compared to the consensus estimate of $21.65 billion. As a group, analysts expect that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 10th. Stockholders of record on Tuesday, May 27th were paid a $1.30 dividend. The ex-dividend date was Tuesday, May 27th. This is an increase from Johnson & Johnson's previous quarterly dividend of $1.24. This represents a $5.20 annualized dividend and a dividend yield of 3.41%. Johnson & Johnson's dividend payout ratio is 57.84%.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.